newsfilter
← Latest News
PR Newswire·

Compugen Reports Second Quarter 2026 Results

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered ...